Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

INCEPTA PHARMS LTD

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 25
  • 0 comments

FDA approve GABAPENTIN

Comment Full text

TEVA

  • FDA Approval
  • Sept. 11, 2024, 08:47 UTC
  • 24
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

HALEON US HOLDINGS

  • FDA Approval
  • Sept. 10, 2024, 18:13 UTC
  • 31
  • 0 comments

FDA approve DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN

Comment Full text

HETERO LABS LTD

  • FDA Approval
  • Sept. 10, 2024, 15:56 UTC
  • 23
  • 0 comments

FDA approve LINAGLIPTIN

Comment Full text

WELDING

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 22
  • 0 comments

FDA approve CABERGOLINE

Comment Full text

ALVOGEN

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 28
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 22
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

AM REGENT

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 16
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text

HOSPIRA

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 25
  • 0 comments

FDA approve VERAPAMIL HYDROCHLORIDE

Comment Full text

CHENGDU SHUODE

  • FDA Approval
  • Sept. 10, 2024, 08:50 UTC
  • 21
  • 0 comments

FDA approve NICARDIPINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 265
  • 266
  • 267
  • 268
  • 269
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168776)
  • FDA Approval(9377)
  • Company Report(721)
  • Business News(112444)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin